Select Medical Holdings Co. (NYSE:SEM – Free Report) – Research analysts at Zacks Research issued their Q1 2025 earnings per share estimates for Select Medical in a note issued to investors on Thursday, March 6th. Zacks Research analyst Z. Masood expects that the health services provider will earn $0.43 per share for the quarter. The consensus estimate for Select Medical’s current full-year earnings is $1.17 per share. Zacks Research also issued estimates for Select Medical’s Q2 2025 earnings at $0.25 EPS, Q3 2025 earnings at $0.20 EPS, Q4 2025 earnings at $0.27 EPS, FY2025 earnings at $1.15 EPS, Q1 2026 earnings at $0.31 EPS, Q2 2026 earnings at $0.50 EPS, Q3 2026 earnings at $0.32 EPS, Q4 2026 earnings at $0.31 EPS and FY2026 earnings at $1.44 EPS.
Select Medical (NYSE:SEM – Get Free Report) last posted its earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.11). The firm had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.50 billion. Select Medical had a net margin of 3.23% and a return on equity of 14.04%.
Check Out Our Latest Research Report on Select Medical
Select Medical Stock Down 2.4 %
SEM opened at $16.99 on Monday. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The firm has a market cap of $2.19 billion, a P/E ratio of 10.29, a PEG ratio of 0.64 and a beta of 1.56. Select Medical has a 52 week low of $16.20 and a 52 week high of $40.98. The business’s fifty day simple moving average is $18.88 and its 200 day simple moving average is $26.62.
Institutional Investors Weigh In On Select Medical
Hedge funds and other institutional investors have recently bought and sold shares of the business. Principal Financial Group Inc. increased its holdings in shares of Select Medical by 6.7% in the 3rd quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock valued at $82,208,000 after acquiring an additional 147,032 shares during the last quarter. Versor Investments LP bought a new stake in shares of Select Medical in the 3rd quarter valued at approximately $1,245,000. Victory Capital Management Inc. increased its holdings in shares of Select Medical by 0.6% in the 3rd quarter. Victory Capital Management Inc. now owns 1,181,078 shares of the health services provider’s stock valued at $41,184,000 after acquiring an additional 7,372 shares during the last quarter. KBC Group NV increased its holdings in shares of Select Medical by 4.5% in the 3rd quarter. KBC Group NV now owns 13,050 shares of the health services provider’s stock valued at $455,000 after acquiring an additional 563 shares during the last quarter. Finally, Royce & Associates LP increased its holdings in shares of Select Medical by 0.6% in the 3rd quarter. Royce & Associates LP now owns 346,675 shares of the health services provider’s stock valued at $12,089,000 after acquiring an additional 1,910 shares during the last quarter. 89.48% of the stock is currently owned by hedge funds and other institutional investors.
Select Medical Cuts Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, March 13th. Investors of record on Monday, March 3rd will be given a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 1.47%. The ex-dividend date is Monday, March 3rd. Select Medical’s dividend payout ratio (DPR) is presently 15.15%.
Select Medical Company Profile
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Read More
- Five stocks we like better than Select Medical
- What is Insider Trading? What You Can Learn from Insider Trading
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Differences Between Momentum Investing and Long Term Investing
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- The Risks of Owning Bonds
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.